Actively Recruiting
Serum Biomarkers in Parkinson's Disease at Different Stages
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2023-03-15
200
Participants Needed
1
Research Sites
302 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
* Determine clinical characteristics of parkinsonian patients in various stages of disease; * Measure peripheral neurodegeneration, synaptic, and inflammation biomarkers in a population of parkinsonian patients at various stages of disease. * Measure vesicular neurodegeneration, synaptic and inflammation biomarkers
CONDITIONS
Official Title
Serum Biomarkers in Parkinson's Disease at Different Stages
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with idiopathic PD according to Movement Disorders Society (MDS) criteria
- Age between 18 and 80 years
- Signed informed consent to participate in this study
You will not qualify if you...
- Women who are pregnant
- Presence of inflammatory or autoimmune diseases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Flavia Torlizzi
Roma, Italy, 00168
Actively Recruiting
Research Team
G
Giulia Di Lazzaro, MD
CONTACT
F
Flavia Torlizzi
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here